ecancer

Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction

Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The Netherlands

3 Dec 2013

Immuno-Oncology: a concept or already a reality?

Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK

3 Dec 2013

Why are Immuno-Oncology compounds different?

Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain

3 Dec 2013

Goals of AORTIC 2013 meeting

Dr Ahmed Elzawawy – President Elect of AORTIC

2 Dec 2013

Psycho-social distress from diagnosis of cancer

Dr Jimmie Holland – Memorial Sloan Kettering Cancer Center, New York, USA

2 Dec 2013

Cancer staging as a form of control

Dr Mary Gospodarowicz - Princess Margaret Cancer Centre, University of Toronto, Canada

2 Dec 2013

Investigating tumour subtypes of Kaposi's Sarcoma

Dr Aron Abera - MRC/Research Group for Receptor Biology, IIDMM, University of Cape Town, South Africa

2 Dec 2013

Use of aspirin by general practitioners

Dr Tom Smith

29 Nov 2013

Elderly population needs new definition to inform treatment decisions

Dr Reinhard Stauder, Prof Mario Boccadoro

27 Nov 2013

Expert care is needed for elderly haematology patients

Prof Matti Aapro, Dr Lodovico Balducci, Prof Mario Boccadoro, Prof Anders Österborg

27 Nov 2013

Mobile health solutions for breast cancer management in rural areas

Dr Ophira Ginsburg – University of Toronto, Canada

27 Nov 2013

Overview of the AORTIC 2013 scientific programme

Dr Seringe Gueye - Hospital General de Grand Yoff, Senegal

27 Nov 2013

More from ecancer